Cargando…
下调HOTAIR通过提高PTEN表达逆转HCC827细胞吉非替尼耐药
BACKGROUND AND OBJECTIVE: Lung cancer is the most common cancer worldwide with the highest morbidity and mortality, in which the non-small cell lung cancer accounts for 80% of all cases. The expression of (HOX transcript antisense RNA) HOTAIR were abnormal in a variety of tumor tissues and is involv...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519959/ https://www.ncbi.nlm.nih.gov/pubmed/32773006 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.103.13 |
Ejemplares similares
-
干扰FOXC1逆转非小细胞肺癌吉非替尼耐药的作用
Publicado: (2021) -
吉非替尼耐药的人肺腺癌HCC-827/GR细胞乙醛脱氢酶亚型表达分析
Publicado: (2018) -
吉非替尼可能通过EGFR启动子甲基化诱导肺腺癌细胞继发性耐药
Publicado: (2015) -
TRIM24介导肺癌细胞吉非替尼耐药机制探讨
Publicado: (2016) -
下调βⅢ-tubulin逆转肺腺癌A549/Taxol细胞株紫杉醇耐药
Publicado: (2014)